• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bausch + Lomb Corporation Common Shares (NY:BLCO)

15.52 +0.51 (+3.40%)
Official Closing Price Updated: 7:00 PM EDT, Sep 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 723,118
Open 15.07
Bid (Size) 15.30 (1)
Ask (Size) 15.95 (1)
Prev. Close 15.01
Today's Range 14.89 - 15.56
52wk Range 10.45 - 21.69
Shares Outstanding 353,700,000
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Bausch + Lomb (BLCO) Stock Trades Up, Here Is Why
Today 16:30 EDT
Shares of eyecare company Bausch + Lomb (NYSE:BLCO) jumped 2.9% in the afternoon session after the company announced the U.S. launch of its ASANA gas permeable (GP) lenses. This new product line offers... 
Via StockStory
Topics Economy Initial Public Offering Stocks
Bausch + Lomb Launches ASANA™ Gas Permeable Lenses in the United States
Today 7:00 EDT
From Bausch + Lomb Corporation
Via Business Wire

Performance

YTD
-13.8%
-13.8%
1 Month
+13.9%
+13.9%
3 Month
+29.5%
+29.5%
6 Month
-2.4%
-2.4%
1 Year
-1.5%
-1.5%

More News

Read More
3 Healthcare Stocks Walking a Fine Line
September 05, 2025
Via StockStory
Topics Stocks
Earnings Scheduled For July 30, 2025
July 30, 2025
Via Benzinga
Examining the Future: Bausch & Lomb's Earnings Outlook
July 29, 2025
Via Benzinga
Bausch + Lomb (BLCO) Stock Is Up, What You Need To Know
August 22, 2025
Via StockStory
Topics Economy Initial Public Offering Stocks
Purple, Bausch + Lomb, Etsy, Intel, and Camping World Shares Are Falling, What You Need To Know
August 21, 2025
Via StockStory
Topics Economy Stocks
Medical Devices & Supplies - Specialty Stocks Q2 Highlights: Bausch + Lomb (NYSE:BLCO)
August 20, 2025
Via StockStory
Bausch + Lomb Announces Board Changes
August 18, 2025
From Bausch + Lomb Corporation
Via Business Wire
1 Safe-and-Steady Stock with Competitive Advantages and 2 That Underwhelm
August 15, 2025
Via StockStory
Bausch + Lomb to Participate in Upcoming Investor Conferences
August 14, 2025
From Bausch + Lomb Corporation
Via Business Wire
Sotera Health Company, Incyte, Exact Sciences, Bausch + Lomb, and Addus HomeCare Shares Skyrocket, What You Need To Know
August 13, 2025
Via StockStory
Topics Economy Lawsuit
BLCO Q2 Deep Dive: Product Launches Offset Margin Pressures, Management Highlights Pipeline Investments
August 12, 2025
Via StockStory
1 Stock Under $50 to Target This Week and 2 We Ignore
August 07, 2025
Via StockStory
3 Small-Cap Stocks with Warning Signs
August 06, 2025
Via StockStory
Bausch Lomb (BLCO) Q2 Revenue Rises 5%
July 30, 2025
Via The Motley Fool
Why Bausch + Lomb (BLCO) Stock Is Down Today
July 30, 2025
Via StockStory
Topics Artificial Intelligence Initial Public Offering
Bausch + Lomb’s (NYSE:BLCO) Q2 Sales Top Estimates, Full-Year Outlook Slightly Exceeds Expectations
July 30, 2025
Via StockStory
Bausch + Lomb Announces Second-Quarter 2025 Results
July 30, 2025
From Bausch + Lomb Corporation
Via Business Wire
Bausch Health Adds Late-Stage Ready Alcohol Liver Disease Drug Candidate In $63 Million DURECT Buyout
July 29, 2025
Via Benzinga
Bausch + Lomb Announces Publication of Phase 3 Data on LUMIFY® Preservative Free Redness Reliever Eye Drops
July 29, 2025
From Bausch + Lomb Corporation
Via Business Wire
Bausch + Lomb (BLCO) Q2 Earnings Report Preview: What To Look For
July 28, 2025
Via StockStory
Topics Artificial Intelligence
Artificial Intelligence Influence in Ophthalmology Industry Projected to Create a Billion Dollar Revenue Opportunity
July 22, 2025
Via FinancialNewsMedia
Topics Artificial Intelligence
Medical Devices & Supplies - Specialty Stocks Q1 In Review: Bausch + Lomb (NYSE:BLCO) Vs Peers
July 20, 2025
Via StockStory
Deal Dispatch: Del Taco Tanks, Tylenol Maker Aches For Change, Joyebells Burns The Pie
July 18, 2025
Via Benzinga

Frequently Asked Questions

Is Bausch + Lomb Corporation Common Shares publicly traded?
Yes, Bausch + Lomb Corporation Common Shares is publicly traded.
What exchange does Bausch + Lomb Corporation Common Shares trade on?
Bausch + Lomb Corporation Common Shares trades on the New York Stock Exchange
What is the ticker symbol for Bausch + Lomb Corporation Common Shares?
The ticker symbol for Bausch + Lomb Corporation Common Shares is BLCO on the New York Stock Exchange
What is the current price of Bausch + Lomb Corporation Common Shares?
The current price of Bausch + Lomb Corporation Common Shares is 15.52
When was Bausch + Lomb Corporation Common Shares last traded?
The last trade of Bausch + Lomb Corporation Common Shares was at 09/08/25 07:00 PM ET
What is the market capitalization of Bausch + Lomb Corporation Common Shares?
The market capitalization of Bausch + Lomb Corporation Common Shares is 5.49B
How many shares of Bausch + Lomb Corporation Common Shares are outstanding?
Bausch + Lomb Corporation Common Shares has 5B shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap